Task-Shifting Adapted IPT-A for Youth Suicide Prevention

May 8, 2026 updated by: Boston College

Youth Mentor-Led Brief Interpersonal Psychotherapy for Youth Suicide Prevention

The goal of this randomized pragmatic clinical trial is to examine the feasibility, acceptability, and mechanisms of change of a brief adaptation of Interpersonal Psychotherapy for Adolescents (BIPT-A), adapted and task-shifted to lay providers (mentors, youth trusted adults) in youth community centers (YCCs) as an upstream approach to suicide.

It focuses on Hispanic adolescents ages 12-17 enrolled in these YCCs. The pragmatic clinical trial will evaluate the acceptability and feasibility of adapted IPT-A delivered by mentors in YCCs and whether adapted BIPT-A impacts mechanisms of change (depressive symptoms, belongingness, and burdensomeness or feeling like a burden to others).

The main questions to answer are:

  • Is adapted BIPT-A, when delivered by trained lay providers (youth mentors), feasible and acceptable in youth community centers?
  • Does adapted BIPT-A, delivered by lay providers, change key risk factors (i.e., key mechanisms: depressive symptoms, low belongingness, and perceived burdensomeness) associated with suicide ideation? The investigators will compare adolescents randomized to adapted BIPT-A (6 sessions) delivered by a trained youth mentor with those receiving usual services at the community center (one individual session focused on active listening).

Participants will:

  1. Be screened for subthreshold depression using the Patient Health Questionnaire Adolescent version (PHQ-A). Adolescent participants will be included if they score between 4 and 9 (mild depression). Participants with a PHQ-A score of 10 or higher (severe depression) will not be eligible and will be referred to a licensed mental health provider for appropriate care.
  2. Be randomized to adapted BIPT-A or usual care. Adolescent participants in the intervention arm will participate in 6 weekly, adapted BIPT-A sessions with a trained youth mentor. Intervention focuses on education, affect identification, and interpersonal skills.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

46

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Carolina Vélez-Grau, PhD and LCSW
  • Phone Number: 16175522539
  • Email: velezgra@bc.edu

Study Contact Backup

Study Locations

    • Massachusetts
      • Chestnut Hill, Massachusetts, United States, 02467
        • Boston College
        • Contact:
          • Carolina Vélez-Grau, PhD, LCSW
          • Phone Number: 6175522539
          • Email: velezgra@bc.edu
        • Contact:
        • Principal Investigator:
          • Carolina Vélez-Grau, PHD, LCSW

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Parent consent
  2. Adolescent consent
  3. Enrolled in youth community centers
  4. Self-identified as Hispanic or Latine
  5. Between 12 and 17 years old.
  6. Scoring threshold for depression (4-9) as indicated in the PHQ-A.
  7. No current report of suicide ideation with plan or self-harming behaviors

Exclusion Criteria:

  1. Not consented to participate in the study
  2. Scoring 10 or higher in the PHQ-A, indicating depressive disorder
  3. Active suicide ideation (i.e., having thoughts of killing oneself, thinking about how in the past month).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Usual Community Center Services
Participants in this arm will continue to receive the standard youth programming and services offered at the participating community centers. This is an individual session focused on active listening.
Participants in this arm will continue to receive the standard youth programs and services offered by the youth community centers, including mentoring, academic support, and recreational activities. They will not receive BIPT-A.
Other Names:
  • Usual Care
  • Standard Youth Programming
Experimental: Adapted IPT-A Delivered by Youth Mentors
Participants in this arm will receive 6 weekly sessions of an adapted, brief Interpersonal Psychotherapy for Adolescents (BIPT-A) delivered by trained youth mentors (n=5) at the partnering youth community centers. The intervention focuses on improving interpersonal functioning, communication skills, and supportive relationships to reduce depressive symptoms, low belongingness, and perceived burdensomeness.
Adolescents in this intervention will receive 6 weekly sessions of an adapted brief version of Interpersonal Psychotherapy for Adolescents (BIPT-A), delivered by trained lay providers (i.e., youth mentors) in youth community centers. The adaptation used a community-participatory research approach to culturally and contextually meet the needs of immigrant-origin inner-city adolescents. The adapted intervention keeps core elements (education, affect identification, and interpersonal skills) and bolsters these skills to target belongingness and burdensomeness, which are factors associated with suicide ideation. Sessions follow a structured, manualized approach. The goal is to reduce depressive symptoms, increase sense of belongingness, and decrease perceived burdensomeness among adolescents with subthreshold depression (score between 4-9 in the PHQ-A).
Other Names:
  • IPT-A
  • BIPT-A

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feasibility of the intervention
Time Frame: Up to 7 weeks.
The Feasibility of Intervention Measure (FIM) is a 4-item self-report survey (Weiner et al., 2017) used to assess whether the intervention can be successfully carried out (feasible). The scores for the 4 items are averaged, yielding a total score of 1-5, where 1-2 indicates low perceived feasibility, 3 indicates moderate, and 4-5 indicates high perceived feasibility. In summary, higher scores indicate higher perceived feasibility (a better outcome).
Up to 7 weeks.
Acceptability of the intervention
Time Frame: Up to 7 weeks
The Acceptability and Appropriateness of Intervention Measure (AIM) is an 8-item self-report survey that assesses whether the intervention is satisfactory (acceptability) and relevant (appropriateness). The measure is divided into 4-item subscales: acceptability and appropriateness. These constructs are evaluated separately, with an average score ranging from 1 (low) to 5 (high) (Weiner et al., 2017). Higher scores indicate higher satisfaction (acceptability) and relevance (appropriateness), meaning a better outcome.
Up to 7 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in depressive symptoms
Time Frame: Up to 7 weeks.

Depressive symptoms are one of the study's mechanisms of change associated with passive suicide ideation.

Depressive symptoms will be measured with the Patient Health Questionnaire-9 Adolescent version (PHQ-A), a 9-item self-report scale. PHQ-A has been validated with the adolescent and Hispanic populations. Most studies use ≥10 as the cutoff score, indicating clinically significant depressive symptoms among adolescents. The total score is the sum of all 9 items (0-27), where 0-4 is minimal or no depression, 5-9 mild depression, 10-14 moderate depression, 15-19 moderately severe depression, and 20-27 severe depression. In summary, higher scores indicate greater severity of depressive symptoms (a worse outcome).

Up to 7 weeks.
Change in interpersonal factors associated with passive suicide ideation.
Time Frame: Up to 7 weeks.

Thwarted Belongingness (TB) and Perceived Burdensomeness (PB) are two factors associated with passive suicide ideation. These two factors are mechanisms of change targeted by the intervention.

The Interpersonal Needs Assessment (INQ-15) measures the extent to which individuals believe they belong (i.e., TB using 9 items) or perceive themselves as a burden to others (i.e., PB using 6 items), which are scored separately, one for TB and one for PB.

Scholars use either the sum score or the average. This study will use mean scores because they preserve the 1-7 scale and provide easier, consistent interpretation. Higher scores indicate higher Thwarted Belongingness and Perceived Burdensomeness (worse outcomes).

Up to 7 weeks.

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in anxiety symptoms
Time Frame: Up to 7 weeks.

Due to the co-occurrence of depressive symptoms with anxiety among adolescents, the investigators will measure anxiety symptoms. The Generalized Anxiety Disorder (GAD-7), a 7-item self-report scale to assess anxiety, will be used to measure anxiety symptoms.

A score of 10 or above typically indicates clinically significant anxiety symptoms and the need for further evaluation. The items (7) are summed, with scores ranging from 0 to 21, where 0-4 indicates minimal anxiety, 5-9 mild anxiety, 10-14 moderate anxiety, and 15-21 severe anxiety. Higher scores indicate greater anxiety severity (a worse outcome).

Up to 7 weeks.
Change in experiences with discrimination
Time Frame: Up to 7 weeks.
The Adolescent Discrimination Distress Index (ADDI; Fisher, Scyatta, & Fenton, 2000) is a 15-item measure that assesses adolescent distress in response to perceived instances of racially motivated discrimination in institutional (e.g., stores, restaurants), educational (e.g., teacher evaluations), and peer contexts. It was developed to examine the nature and impact of racial and ethnic discrimination on development in multiethnic samples of youth. Students indicate whether they have experienced each type of discrimination because of their race or ethnicity and, if so, they rate how much it upset them, on a 5-point scale ranging from not at all to extremely. Total score range (15-75 using a sum). Higher scores indicate higher levels of distress (a worse outcome).
Up to 7 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Carolina Vélez-Grau, PHD, LCSW, Boston College
  • Study Chair: Laura Mufson, PhD, Columbia University
  • Study Chair: Susan Witte, PhD, Columbia University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

August 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

July 31, 2028

Study Registration Dates

First Submitted

January 25, 2026

First Submitted That Met QC Criteria

January 26, 2026

First Posted (Actual)

February 3, 2026

Study Record Updates

Last Update Posted (Actual)

May 12, 2026

Last Update Submitted That Met QC Criteria

May 8, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • 24.274
  • K23MH137405 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The National Institute of Mental Health (NIMH) Data Archive (NDA) will be used. NDA is an NIH-funded collaborative resource that contains harmonized human subjects research data. Data submitted to the NDA is stripped of identifiers.

IPD Sharing Time Frame

Data will be available at the end of the study in 2029.

IPD Sharing Access Criteria

Based on the NDA, the qualified scientific community will have access to de-identified data from the study.

IPD Sharing Supporting Information Type

  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Suicidal Ideation

Clinical Trials on Usual Community Center Services

Subscribe